Search research articles
Contact Us
Filters
Showing results (21-30 of 212) with videos related to
Page
of 22
Sort By:
Reviews on Recent Clinical Trials
|
October 21, 2014
Evolving treatments in multiple myeloma patients with renal failure
Alessandro Gozzetti, Giulia Papini, Veronica Candi, et al.
European Journal of Haematology
|
November 16, 2011
Plasmacytoma of the skull
Alessandro Gozzetti, Alfonso Cerase, Marzia Defina, et al.
Annals of Hematology
|
February 25, 2012
Extramedullary myeloma relapses
Alessandro Gozzetti, Giulia Papini, Marzia Defina, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2010
Lenalidomide efficacy in bortezomib-resistant myeloma
Alessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Frontiers in Oncology
|
September 20, 2014
Therapeutic advancements in multiple myeloma
Alessandro Gozzetti, Veronica Candi, Giulia Papini, et al.
Cancer
|
February 3, 2011
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
Alberto Fabbri, Alberto Febbri, Alessandro Gozzetti, et al.
Frontiers in Oncology
|
April 1, 2022
Editorial: Molecular Mechanisms of Multiple Myeloma
Alessandro Gozzetti, Chung Hoow Kok, Chien-Feng Li
Annals of Hematology
|
February 4, 2010
Hyperlipidemic myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
Nature Reviews. Clinical Oncology
|
August 12, 2010
Predicting the clinical course of Hodgkin lymphoma
Alberto Fabbri, Alessandro Gozzetti, Francesco Forconi, et al.
Leukemia & Lymphoma
|
October 15, 2014
Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders
Alessandro Gozzetti, Alberto Fabbri, Emanuele Cencini, et al.
Page
of 22
Search research articles
Search
Showing results (21-30 of 212) with videos related to
Sort By:
Page
of 22
Reviews on Recent Clinical Trials
|
October 21, 2014
Evolving treatments in multiple myeloma patients with renal failure
Alessandro Gozzetti, Giulia Papini, Veronica Candi, et al.
European Journal of Haematology
|
November 16, 2011
Plasmacytoma of the skull
Alessandro Gozzetti, Alfonso Cerase, Marzia Defina, et al.
Annals of Hematology
|
February 25, 2012
Extramedullary myeloma relapses
Alessandro Gozzetti, Giulia Papini, Marzia Defina, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2010
Lenalidomide efficacy in bortezomib-resistant myeloma
Alessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Frontiers in Oncology
|
September 20, 2014
Therapeutic advancements in multiple myeloma
Alessandro Gozzetti, Veronica Candi, Giulia Papini, et al.
Cancer
|
February 3, 2011
Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma
Alberto Fabbri, Alberto Febbri, Alessandro Gozzetti, et al.
Frontiers in Oncology
|
April 1, 2022
Editorial: Molecular Mechanisms of Multiple Myeloma
Alessandro Gozzetti, Chung Hoow Kok, Chien-Feng Li
Annals of Hematology
|
February 4, 2010
Hyperlipidemic myeloma
Alessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
Nature Reviews. Clinical Oncology
|
August 12, 2010
Predicting the clinical course of Hodgkin lymphoma
Alberto Fabbri, Alessandro Gozzetti, Francesco Forconi, et al.
Leukemia & Lymphoma
|
October 15, 2014
Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders
Alessandro Gozzetti, Alberto Fabbri, Emanuele Cencini, et al.
Page
of 22